Articles in section Mergers & Acquisitions
| << Licensing | 371 articles | Opinion & Analysis >> |
| Next >> |
-
Bayer Boosts Contraceptive Business with US$1.1 B Conceptus Purchase
-
Shire Adds Phase III Ophthalmology Asset to Pipeline with SARcode Bioscience Purchase
-
Valeant Increases Offer for Obagi Medical Products After Merz Pharma Bid
-
Ajinomoto Expands Biologics Development and Manufacturing Capabilities with Althea Technologies Purchase
-
Mylan Bolsters Global Injectables Business with Deal to Acquire Agila Specialities from Strides Arcolab
-
Cubist Gains Option to Acquire Adynxx with Diversification in Mind
-
Eisai Divests US Rights to CTCL Therapy Targretin® to Valeant
-
Biogen Idec Buys Complete Ownership of Tysabri® from Elan
-
Actavis Expands in Women’s Health with Uteron Pharma Purchase
-
Baxter Buys Late-Stage Haemophilia Drug OBI-1 from Ipsen and Troubled Inspiration Biopharmaceuticals



RSS